Old Web
English
Sign In
Acemap
>
authorDetail
>
Kristian Michael Koller
Kristian Michael Koller
Pennsylvania State University
Pathology
Medicine
Monoclonal antibody
Internal medicine
overall survival
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Overall survival in patients with metastatic melanoma treated with concurrent ipilimumab and radiotherapy.
2016
Journal of Clinical Oncology
Kristian Michael Koller
Heath B. Mackley
Henry N. Wagner
Giampaolo Talamo
Todd D. Schell
Colette R. Pameijer
Rogerio I. Neves
Bryan Anderson
Kathleen M. Kokolus
Carol Mallon
Joseph J. Drabick
Show All
Source
Cite
Save
Citations (0)
Concurrent ipilimumab and radiotherapy in patients with metastatic melanoma: A retrospective analysis.
2015
Journal of Clinical Oncology
Kristian Michael Koller
Heath B. Mackley
Henry N. Wagner
Rogerio I. Neves
Todd D. Schell
Bryan Anderson
Colette R. Pameijer
Carol Mallon
Joseph J. Drabick
Show All
Source
Cite
Save
Citations (1)
Target wise and pound foolish: A simple technique to evaluate the trade-off between economic burden and clinical benefit of monoclonal antibodies.
2015
Journal of Clinical Oncology
Matthew Brennan
Timothy J Brown
Kristian Michael Koller
Monali K. Vasekar
Peter Hubert Cygan
Jeffrey Michael Sivik
Michael Glantz
Show All
Source
Cite
Save
Citations (0)
1